TB Alliance

Watal is presently Chairman, Central Vista Oversight Committee, Ministry of Housing and Urban Affairs, Government of India

Pretomanid is part of two new treatment regimens with high efficacy and shorter treatment durations recently recommended by the…

Based on new clinical evidence presented and published over the past year, the new guidelines allow for the programmatic…

The DCGI (Drug Controller General of India) approved TB drug, pretomanid, for conditional access under the National Tuberculosis…

Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories, including many…

The results from the trial were announced ahead of an oral abstract presentation next week at the 11th IAS Conference on HIV…